Symbol: |
EVPL
|
Description: |
envoplakin [Source:HGNC Symbol;Acc:3503]
|
Location: |
Chr17:74002927-74023507[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:130
Gene |
Compound |
Gen_sig |
Exp_pattern |
EVPL |
4-Benzylidene-2-phenyl-5(4H)-oxazolone |
0.004 |
Up |
EVPL |
NSC 37031 |
0.005 |
Up |
EVPL |
Maxima isoflavone D |
0.043 |
Up |
EVPL |
C.I. 37559 |
0.006 |
Up |
EVPL |
NSC 527353 |
0.019 |
Down |
EVPL |
RAPAMYCIN PRODRUG |
0.009 |
Up |
EVPL |
Benzo[1,2-c:4,5-c']dipyrrole-1,3,5,7(2H,6H)-tetraimine |
0.047 |
Up |
EVPL |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(2-methoxy- phenyl)methylene]-, hydrochloride |
0.033 |
Down |
EVPL |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.018 |
Up |
EVPL |
Oxalic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d] thiazol-2-yl)hydrazide, monoethyl ester |
0.012 |
Up |
EVPL |
23,27-Epoxy-3H-pyrido[2,1-c] [1,4]oxaazacyclohentriacontine-1,5,11,28,29-pentone-, 1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31, 32,33,34,34a-tetracosahydro- 27-hydroxy-10,21-dimethoxy-3-[2-[3-methoxy-4-[1-oxo- 3-(dimethylamino)propoxy]cyclohexy |
0.022 |
Up |
EVPL |
1,4-BIS(DIETHYLAMINO)-5,8-DIHYDROXY ANTHRAQUINON |
0.019 |
Up |
EVPL |
2-Propen-1-one, 1-(4-chlorophenyl)-3-[4-[2-oxo- 2-(4-phenyl-1-piperazinyl)ethoxy]phenyl]-, (E)- |
0.021 |
Up |
EVPL |
NSC 651668 |
0.023 |
Up |
EVPL |
NSC 65683 |
0.026 |
Up |
Expression pattern: Sensitivity / Resistance
Total:9 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:6
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:52
Total:4 Current:1
[First] [Prev]  Next Last 
|